| 摘要 |
FIELD: medicine.SUBSTANCE: group of inventions relates to medicine, namely to ophthalmology, and can be used for the reduction or inhibition of angiogenesis in an individual, suffering from an eye disease, or a condition, associated with angiogenesis. For this purposethe antagonist TSPAN12 is introduced to the individual. Also claimed is a method of treating the disease or a condition of eyes, associated with undesirable angiogenesis.EFFECT: group of inventions provides reduction of angiogenesis of vessels of the outer plexiform layer (OPL), connected with the layer of nerve fibres (NFL) of the optic nerve.30 cl, 13 dwg, 1 tbl, 7 ex |
